Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yisaipu in Active Axial Spondyloarthritis
NCT02364479Phase 4Completed
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2014
- Primary completion
- Jul 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etanercept in non-radiographic axial spondyloarthritis (nr-axSpA) (3 arms), sponsored by Sun Yat-sen University. Primary endpoint: Proportion of patients achieving Ankylosing Spondylitis Disease Activity Score < 2.1 at 72 weeks. Started Feb 2014; status: completed.
02
Drugs
etanercept
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT02364479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02364479.